Failure of vitamin B6 to reverse the l-dopa effect in patients on a dopa decarboxylase inhibitor
暂无分享,去创建一个
[1] S. Yatziv,et al. [Subacute necrotizing encephalomyelopathy]. , 1972, Harefuah.
[2] A. Barbeau,et al. Treatment of Parkinson's disease with levodopa and Ro 4‐4602 , 1971, Clinical pharmacology and therapeutics.
[3] D. Shenker,et al. THEORETICAL IMPLICATIONS OF THE USE OF L‐DOPA IN PARKINSONISM. , 1970, Acta neurologica Scandinavica.
[4] M. Bowers. Cerebrospinal fluid 5-hydroxyindoles and behavior after L-tryptophan and pyridoxine adminstration to psychiatric patients. , 1970, Neuropharmacology.
[5] G. Crane,et al. Failure of pyridoxine to reduce drug-induced dyskinesias , 1970, Journal of neurology, neurosurgery, and psychiatry.
[6] R. Watts,et al. The action of pyridoxine in primary hyperoxaluria. , 1970, Clinical science.
[7] R. J. Pellegrino,et al. Impairment of pyridoxal phosphate dependent metabolic reactions in a child with subacute necrotizing encephalopathy. , 1969, Journal of neurology, neurosurgery, and psychiatry.
[8] R. Duvoisin,et al. Treatment of parkinsonism with levodopa. , 1969, Archives of neurology.
[9] W. Weiner,et al. L-dopa and cerebrospinal fluid homovanillic acid in Parkinsonism. , 1969, Life sciences.
[10] George C. Cotzias,et al. Modification of Parkinsonism--chronic treatment with L-dopa. , 1969, The New England journal of medicine.
[11] W. Burkard,et al. Increase of Cerebral Catecholamines caused by 3,4-Dihydroxyphenylalanine after Inhibition of Peripheral Decarboxylase , 1967, Nature.
[12] R. Tissot,et al. Metabolic fate of l-[14C] DOPA in cerebrospinal fluid and blood plasma of humans. , 1967, Brain research.
[13] O. Hornykiewicz. Dopamine (3-hydroxytyramine) and brain function. , 1966, Pharmacological reviews.
[14] Å. Bertler,et al. The localization of monoaminergic blood-brain barrier mechanisms. , 1966, Pharmacological reviews.
[15] L. Laster,et al. Cystathioninuria , 1963, British medical journal.
[16] J. Changeux,et al. Allosteric proteins and cellular control systems. , 1963, Journal of molecular biology.
[17] G. Canter,et al. A METHOD FOR EVALUATING DISABILITY IN PATIENTS WITH PARKINSON'S DISEASE , 1961, The Journal of nervous and mental disease.
[18] J. Monod,et al. Genetic regulatory mechanisms in the synthesis of proteins. , 1961, Journal of molecular biology.
[19] H. Klawans,et al. A pharmacologic analysis of Huntington's chorea. , 1970, European neurology.
[20] H. Klawans. The pharmacology of parkinsonism (a review). , 1968, Diseases of the nervous system.
[21] T. Sourkes. Dopa decarboxylase: substrates, coenzyme, inhibitors. , 1966, Pharmacological reviews.
[22] W. Lovenberg,et al. Aromatic L-amino acid decarboxylase. , 1962, The Journal of biological chemistry.